The genetic basis of pulmonary arterial hypertension
- 21 January 2014
- journal article
- review article
- Published by Springer Nature in Human Genetics
- Vol. 133 (5) , 471-479
Abstract
Pulmonary arterial hypertension (PAH) is a rare disease characterized by distinctive changes in pulmonary arterioles that lead to progressive elevation of pulmonary artery pressure, pulmonary vascular resistance, right ventricular failure, and a high mortality rate. The etiology of PAH is heterogeneous and incompletely understood. Based on clinical classification, WHO Group 1 PAH includes sporadic disease (idiopathic PAH), inherited PAH (heritable PAH), and association with certain medical conditions (associated PAH). Genes play an important role in idiopathic and heritable PAH. Mutations in bone morphogenetic protein receptor 2 (BMPR2), a member of the transforming growth factor β (TGFβ) superfamily of receptors, have been identified in 70 % of cases of familial PAH, as well as in 10–40 % of cases of idiopathic PAH. Mutations in ALK-1, ENG, SMAD4 and SMAD8, other TGFβ family members, are additional rare causes of PAH. CAV1 regulates SMAD2/3 phosphorylation, and mutations in CAV1 are a rare cause of PAH. KCNK3 is a member of the two-pore domain potassium channels expressed in pulmonary artery smooth muscle cells, and mutations in KCNK3 are a rare cause of both familial and IPAH. The genetics of PAH are complex due to incomplete penetrance and genetic heterogeneity. In addition to rare mutations as a monogenic cause of HPAH, common variants in cerebellin 2 (CBLN2) increase the risk of PAH by approximately twofold. PAH in children is much more heterogeneous than in adults and can be associated with several genetic syndromes, specifically syndromes with congenital heart disease, vascular disease, and hepatic disease. Clinical genetic testing is available for PAH and should be considered in families to allow for more definitive risk stratification and allow for reproductive planning.Keywords
This publication has 81 references indexed in Scilit:
- Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial HypertensionCirculation: Cardiovascular Genetics, 2012
- Two Cases of Pulmonary Hypertension Associated with Type III Glycogen Storage Disease2011
- Somatic Chromosome Abnormalities in the Lungs of Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial HypertensionCirculation, 2010
- Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertensionRespiratory Research, 2010
- Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2010
- Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertensionRespiratory Research, 2009
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- High Frequency of BMPR2 Exonic Deletions/Duplications in Familial Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutationsJournal of Medical Genetics, 2006